Nifty
Sensex
:
:
11131.85
37668.42
-21.80 (-0.20%)
-65.66 (-0.17%)

Pharmaceuticals & Drugs - Domestic

Rating :
71/99

BSE: 506943 | NSE: JBCHEPHARM

923.10
23-Sep-2020
  • Open
  • High
  • Low
  • Previous Close
  •  1011.00
  •  1030.00
  •  906.15
  •  999.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  642462
  •  6127.79
  •  1149.90
  •  315.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,713.91
  • 23.41
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,715.00
  • 1.10%
  • 4.96

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.91%
  • 1.08%
  • 19.05%
  • FII
  • DII
  • Others
  • 7.78%
  • 13.14%
  • 3.04%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.14
  • 7.58
  • 7.87

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.98
  • 12.88
  • 13.65

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.92
  • 11.04
  • 25.28

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.17
  • 17.20
  • 16.43

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.88
  • 2.28
  • 2.22

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.28
  • 10.45
  • 9.98

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
522.29
446.11
17.08%
443.57
418.91
5.89%
428.63
382.03
12.20%
456.42
435.34
4.84%
Expenses
366.86
350.13
4.78%
351.83
353.90
-0.58%
339.04
304.05
11.51%
356.16
353.84
0.66%
EBITDA
155.42
95.98
61.93%
91.74
65.02
41.10%
89.59
77.98
14.89%
100.26
81.50
23.02%
EBIDTM
29.76%
21.51%
14.01%
15.52%
20.90%
20.41%
21.97%
18.72%
Other Income
22.69
12.61
79.94%
3.17
15.65
-79.74%
16.38
15.82
3.54%
18.51
8.55
116.49%
Interest
3.75
0.80
368.75%
0.50
0.78
-35.90%
0.85
1.30
-34.62%
0.87
0.76
14.47%
Depreciation
17.29
15.80
9.43%
17.39
11.60
49.91%
16.75
14.66
14.26%
16.39
14.69
11.57%
PBT
157.07
91.98
70.77%
67.02
68.28
-1.85%
88.37
77.84
13.53%
101.51
74.60
36.07%
Tax
37.57
29.87
25.78%
16.95
21.49
-21.13%
21.93
27.89
-21.37%
7.75
23.13
-66.49%
PAT
119.51
62.11
92.42%
50.07
46.79
7.01%
66.45
49.95
33.03%
93.76
51.47
82.16%
PATM
22.88%
13.92%
7.11%
11.17%
15.50%
13.08%
20.54%
11.82%
EPS
15.46
8.04
92.29%
6.48
6.05
7.11%
8.60
6.46
33.13%
12.13
6.66
82.13%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,850.91
1,774.73
1,643.20
1,413.77
1,368.32
1,231.58
1,144.21
1,021.86
866.13
801.87
890.79
Net Sales Growth
10.02%
8.00%
16.23%
3.32%
11.10%
7.64%
11.97%
17.98%
8.01%
-9.98%
 
Cost Of Goods Sold
5,147.42
630.80
596.46
542.41
552.00
491.41
341.40
413.95
371.52
320.07
277.04
Gross Profit
-3,296.51
1,143.93
1,046.74
871.35
816.32
740.17
802.81
607.92
494.60
481.80
613.75
GP Margin
-178.10%
64.46%
63.70%
61.63%
59.66%
60.10%
70.16%
59.49%
57.10%
60.08%
68.90%
Total Expenditure
1,413.89
1,397.15
1,337.81
1,214.64
1,135.93
1,025.55
964.09
873.67
760.48
701.55
698.43
Power & Fuel Cost
-
61.54
63.29
58.28
54.89
55.28
53.02
46.61
39.75
29.89
23.34
% Of Sales
-
3.47%
3.85%
4.12%
4.01%
4.49%
4.63%
4.56%
4.59%
3.73%
2.62%
Employee Cost
-
322.92
288.18
251.10
217.34
175.31
159.56
143.67
130.05
112.66
124.93
% Of Sales
-
18.20%
17.54%
17.76%
15.88%
14.23%
13.94%
14.06%
15.02%
14.05%
14.02%
Manufacturing Exp.
-
140.70
150.49
139.83
131.45
119.35
223.53
102.44
61.75
52.97
60.85
% Of Sales
-
7.93%
9.16%
9.89%
9.61%
9.69%
19.54%
10.02%
7.13%
6.61%
6.83%
General & Admin Exp.
-
48.89
52.97
53.96
42.26
34.82
32.46
31.69
27.94
31.31
38.21
% Of Sales
-
2.75%
3.22%
3.82%
3.09%
2.83%
2.84%
3.10%
3.23%
3.90%
4.29%
Selling & Distn. Exp.
-
116.95
113.59
87.44
78.27
72.72
75.13
73.59
56.04
68.65
131.60
% Of Sales
-
6.59%
6.91%
6.18%
5.72%
5.90%
6.57%
7.20%
6.47%
8.56%
14.77%
Miscellaneous Exp.
-
75.36
72.83
81.61
59.72
76.65
79.01
61.72
73.44
86.00
131.60
% Of Sales
-
4.25%
4.43%
5.77%
4.36%
6.22%
6.91%
6.04%
8.48%
10.72%
4.77%
EBITDA
437.01
377.58
305.39
199.13
232.39
206.03
180.12
148.19
105.65
100.32
192.36
EBITDA Margin
23.61%
21.28%
18.59%
14.09%
16.98%
16.73%
15.74%
14.50%
12.20%
12.51%
21.59%
Other Income
60.75
50.90
41.44
55.29
50.16
56.65
10.89
37.70
27.87
28.98
6.16
Interest
5.97
3.26
4.20
3.49
5.37
10.65
6.82
5.93
5.28
24.03
10.49
Depreciation
67.82
66.32
55.64
56.97
47.22
41.22
38.64
28.02
24.66
22.42
22.79
PBT
413.97
358.89
286.99
193.95
229.94
210.82
145.55
151.94
103.57
82.85
165.24
Tax
84.20
76.50
93.02
55.23
45.55
49.58
45.14
25.95
24.13
165.53
25.92
Tax Rate
20.34%
21.93%
32.41%
28.48%
19.81%
23.52%
31.01%
29.68%
23.30%
19.63%
15.69%
PAT
329.79
272.04
193.47
138.34
184.06
161.14
100.41
61.50
79.44
677.91
139.32
PAT before Minority Interest
329.40
272.39
193.97
138.72
184.40
161.24
100.41
61.50
79.44
677.91
139.32
Minority Interest
-0.39
-0.35
-0.50
-0.38
-0.34
-0.10
0.00
0.00
0.00
0.00
0.00
PAT Margin
17.82%
15.33%
11.77%
9.79%
13.45%
13.08%
8.78%
6.02%
9.17%
84.54%
15.64%
PAT Growth
56.80%
40.61%
39.85%
-24.84%
14.22%
60.48%
63.27%
-22.58%
-88.28%
386.58%
 
EPS
42.66
35.19
25.03
17.90
23.81
20.85
12.99
7.96
10.28
87.70
18.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,435.49
1,480.12
1,441.56
1,363.67
1,183.84
994.87
1,042.81
1,020.27
969.95
691.54
Share Capital
15.46
16.05
16.71
16.96
16.96
16.96
16.95
16.94
16.94
16.90
Total Reserves
1,420.03
1,464.08
1,424.84
1,346.70
1,166.87
977.91
1,025.82
1,003.22
952.83
674.31
Non-Current Liabilities
62.72
64.84
45.66
26.98
31.02
32.62
31.93
40.45
39.52
36.50
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.22
0.40
0.54
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.40
0.40
7.03
12.14
11.99
Long Term Provisions
7.39
5.73
9.67
12.56
10.43
12.03
12.19
8.23
8.27
7.71
Current Liabilities
515.77
780.59
736.50
693.46
797.22
459.75
276.27
239.48
188.32
271.33
Trade Payables
123.79
82.76
110.39
98.98
90.85
77.51
60.75
60.51
37.09
50.21
Other Current Liabilities
143.88
126.76
119.75
122.15
138.73
103.74
98.06
101.15
78.75
61.22
Short Term Borrowings
32.04
25.80
29.29
48.86
193.02
126.88
81.71
37.28
55.23
133.36
Short Term Provisions
216.06
545.27
477.06
423.47
374.61
151.62
35.76
40.54
17.26
26.54
Total Liabilities
2,016.48
2,328.35
2,226.49
2,086.29
2,013.75
1,487.24
1,351.01
1,300.20
1,197.79
999.37
Net Block
651.26
620.93
639.50
679.44
440.22
328.56
310.55
334.41
276.31
258.39
Gross Block
1,177.43
1,084.83
1,053.76
1,038.55
753.75
601.67
540.54
537.46
456.51
420.25
Accumulated Depreciation
526.17
463.89
414.25
359.10
313.53
273.11
229.99
203.06
180.19
161.85
Non Current Assets
740.83
741.43
717.89
879.15
831.58
586.31
370.37
356.49
331.58
278.78
Capital Work in Progress
16.17
15.09
17.40
3.76
134.89
55.17
46.36
4.81
39.00
3.75
Non Current Investment
69.45
95.88
49.96
185.84
231.42
184.83
2.75
2.99
3.00
3.94
Long Term Loans & Adv.
3.59
9.10
10.15
9.43
22.63
17.74
10.71
14.28
13.27
12.70
Other Non Current Assets
0.36
0.43
0.88
0.67
2.43
0.00
0.00
0.00
0.00
0.00
Current Assets
1,275.65
1,586.93
1,508.59
1,207.14
1,182.16
900.94
980.65
943.71
866.22
720.60
Current Investments
333.81
360.65
383.77
224.96
247.28
366.78
497.26
394.68
298.92
81.05
Inventories
274.67
243.76
213.73
200.17
187.98
150.27
134.40
104.53
101.03
111.67
Sundry Debtors
345.43
309.30
300.73
265.97
272.64
262.35
235.51
191.27
136.05
345.58
Cash & Bank
30.95
36.80
29.92
13.39
12.90
25.19
11.81
156.23
219.53
126.89
Other Current Assets
290.80
31.33
12.94
14.36
461.34
96.35
101.68
96.99
110.69
55.41
Short Term Loans & Adv.
272.33
605.10
567.50
488.30
458.83
95.97
101.48
96.84
110.29
54.66
Net Current Assets
759.88
806.34
772.10
513.68
384.94
441.19
704.37
704.23
677.90
449.27
Total Assets
2,016.48
2,328.36
2,226.48
2,086.29
2,013.74
1,487.25
1,351.02
1,300.20
1,197.80
999.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
275.37
193.08
122.92
201.13
140.41
126.66
-13.98
84.20
879.69
133.92
PBT
348.89
286.99
193.95
229.94
212.23
145.55
87.44
103.57
843.44
165.34
Adjustment
7.95
22.95
16.91
13.11
-1.40
38.51
20.75
-4.40
33.13
16.60
Changes in Working Capital
9.32
-51.95
-47.07
5.92
-16.96
-19.52
-93.71
9.47
167.35
-15.87
Cash after chg. in Working capital
366.17
257.99
163.79
248.97
193.88
164.53
14.49
108.65
1,043.91
166.07
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-90.80
-64.91
-40.87
-47.84
-53.47
-37.87
-28.47
-24.45
-164.22
-32.15
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
24.30
-26.89
-20.68
-45.31
-27.62
-111.89
-142.50
-116.05
-260.92
-89.46
Net Fixed Assets
-94.42
-29.82
-29.56
-152.86
-187.76
-69.64
-55.43
-41.77
-69.55
-32.72
Net Investments
53.26
-22.80
-22.92
67.89
-14.16
-61.38
-102.46
-95.95
-214.42
-60.83
Others
65.46
25.73
31.80
39.66
174.30
19.13
15.39
21.67
23.05
4.09
Cash from Financing Activity
-306.05
-155.29
-59.52
-183.84
-99.62
-1.39
12.04
-31.45
-526.12
4.56
Net Cash Inflow / Outflow
-6.38
10.90
42.72
-28.02
13.17
13.38
-144.43
-63.30
92.65
49.02
Opening Cash & Equivalents
32.14
21.24
-21.47
6.54
-5.46
11.81
156.23
219.53
126.89
77.86
Closing Cash & Equivalent
25.75
32.14
21.24
-21.47
9.42
25.19
11.81
156.23
219.53
126.89

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
185.75
184.47
172.50
160.77
139.57
117.31
123.07
119.21
113.34
80.86
ROA
12.54%
8.52%
6.43%
8.99%
9.21%
7.08%
4.64%
6.36%
61.71%
15.17%
ROE
18.69%
13.28%
9.89%
14.48%
14.80%
9.86%
5.99%
8.07%
82.49%
22.35%
ROCE
23.69%
19.56%
13.70%
16.87%
17.72%
13.49%
8.50%
10.41%
92.09%
22.63%
Fixed Asset Turnover
1.57
1.54
1.35
1.53
1.82
2.03
1.92
1.76
1.85
2.22
Receivable days
67.22
67.75
73.15
71.84
79.28
78.41
75.30
68.16
108.62
140.48
Inventory Days
53.31
50.81
53.43
51.77
50.12
44.83
42.16
42.80
47.97
39.77
Payable days
32.74
27.31
33.66
32.86
32.45
27.82
26.91
26.15
26.89
25.89
Cash Conversion Cycle
87.79
91.25
92.93
90.75
96.95
95.43
90.54
84.81
129.69
154.35
Total Debt/Equity
0.02
0.02
0.02
0.04
0.16
0.13
0.09
0.05
0.07
0.25
Interest Cover
108.09
69.36
56.54
43.81
20.80
22.33
15.74
20.61
36.10
16.75

News Update:


  • CCI approves proposal of Tau Investment to acquire shares in JB Chemicals
    27th Aug 2020, 12:35 PM

    The proposed combination envisages acquisition of up to 64.90% of the share capital of JB Chemicals & Pharmaceuticals by Tau Investment

    Read More
  • KKR to acquire controlling stake in JB Chemicals & Pharmaceuticals
    3rd Jul 2020, 12:25 PM

    KKR has entered into a definitive agreement to purchase a controlling stake in the company

    Read More
  • JB Chem & Pharma - Quarterly Results
    25th Jun 2020, 15:25 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.